Industry News
Topcon Healthcare Acquires RetInSight to Expand AI-Driven Retinal Imaging Capabilities

Topcon Healthcare has announced its acquisition of RetInSight, a Vienna, Austria-based AI company sp...

read more
Topcon Healthcare Acquires RetInSight to Expand AI-Driven Retinal Imaging Capabilities
May 06, 2025
ZEISS Unveils AI-Powered Research Data Platform for Ophthalmology

ZEISS has announced the introduction of its new ZEISS Research Data Platform (ZEISS RDP)—a cloud-bas...

read more
ZEISS Unveils AI-Powered Research Data Platform for Ophthalmology
May 05, 2025
Palatin Releases Updated Responder Analysis Results from Phase 3 Melody-1 Trial in Dry Eye Disease

Palatin Technologies has announced updated results from responder analyses of its pivotal Phase 3 Me...

read more
Palatin Releases Updated Responder Analysis Results from Phase 3 Melody-1 Trial in Dry Eye Disease
April 30, 2025
Ace Vision Group Closes $29.4 Million Series B Financing to Advance Presbyopia Laser Technology

Ace Vision Group (AVG) has announced the successful closing of a $29.4 million Series B financing ro...

read more
Ace Vision Group Closes $29.4 Million Series B Financing to Advance Presbyopia Laser Technology
April 30, 2025
UNITY Biotechnology Announces NEJM Evidence Publication of Phase 2 UBX1325 Data in DME

UNITY Biotechnology has announced that NEJM Evidence has published results from the Phase 2 BEHOLD s...

read more
UNITY Biotechnology Announces NEJM Evidence Publication of Phase 2 UBX1325 Data in DME
April 29, 2025
iStar Medical Announces Positive 5-Year Results of MINIject in Glaucoma Patients

iStar Medical has announced positive 5-year results from the STAR-GLOBAL trial evaluating the long-t...

read more
iStar Medical Announces Positive 5-Year Results of MINIject in Glaucoma Patients
April 28, 2025
Bausch + Lomb Resolves enVista IOL Recall Issue and Begins Product Relaunch

Bausch + Lomb has identified the root cause of a recent voluntary recall of select intraocular lense...

read more
Bausch + Lomb Resolves enVista IOL Recall Issue and Begins Product Relaunch
April 28, 2025
Positive Topline Results from Phase 2 VVN461 Trial for Non-Infectious Anterior Uveitis

VivaVision Biotech has announced positive topline results from its Phase 2 clinical trial of VVN461,...

read more
Positive Topline Results from Phase 2 VVN461 Trial for Non-Infectious Anterior Uveitis
April 28, 2025
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children

Entod Pharmaceuticals has received marketing authorization from the Central Drugs Standard Control O...

read more
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children
April 24, 2025
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease

Zhaoke Ophthalmology has announced the enrollment of the first patient in its Phase 3 clinical trial...

read more
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease
April 21, 2025
More